MedPath

A Prospective Randomized Study to Compare Neurocognitive Outcome after Gamma Knife Radiosurgery or Whole Brain Radiation Therapy for the Treatment of Multiple Brain Metastases

Recruiting
Conditions
Brain metastases
Registration Number
NL-OMON28765
Lead Sponsor
St Elisabeth Hospital, Tilburg and Tilburg University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
80
Inclusion Criteria

• Histologically proven malignant cancer

• Imaging and clinical presentation consistent with BM; contrast enhanced volumetric MRI used for treatment planning showing 11-20 newly diagnosed BM with a maximum total tumor volume of 30 cm3

Exclusion Criteria

• No prior histologic confirmation of malignancy

• Primary brain tumor, a second (active) primary tumor

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The definition of the primary endpoint is the statistically significant difference in the percentage of patients with significant cognitive decline at three months between treatment groups. Decline is defined as a 5-point decrease from baseline based on the reliable change index (with correction for practice effects) in HVLT-R Total Recall score.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath